ClinConnect ClinConnect Logo
Search / Trial NCT03280732

Use of Lung Ultrasound in Children With Acute Bronchiolitis

Launched by IRCCS AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA · Sep 10, 2017

Trial Information

Current as of September 03, 2025

Completed

Keywords

Lung Ultrasound Chest X Ray Pneumonia Pneumothorax Pleural Effusion

ClinConnect Summary

Bronchiolitis is the most common lower respiratory tract infection that affects children younger than 24 months. The diagnosis is clinical and, according to international guidelines, chest x-ray (CXR) should be reserved for cases in which signs of pulmonary complications are present or where respiratory effort is severe to warrant intensive care unit admission. Despite these recommendations, CXR is still performed in about 50% of bronchiolitis (ranging from 24 to 77%), which exposes infants to ionizing radiation.

Given its portability, no ionizing radiation, rapid and repeat testing, lung ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Children hospitalized with a diagnosis of bronchiolitis
  • Age \< 24 months
  • CXR as part of usual clinical practice because of clinical suspicion of pulmonary complications
  • Informed written consent
  • Exclusion Criteria:
  • chronic respiratory disease (i.e. bronchopulmonary dysplasia)
  • congenital heart disease
  • severe neuromuscular disease
  • congenital or acquired immunodeficiency

About Irccs Azienda Ospedaliero Universitaria Di Bologna

IRCCS Azienda Ospedaliero-Universitaria di Bologna is a prestigious research and healthcare institution in Italy, renowned for its commitment to advancing medical science and patient care through innovative clinical research. As an IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), it integrates clinical practice with scientific research, facilitating the translation of laboratory findings into effective treatment strategies. The institution fosters a multidisciplinary approach, collaborating with various experts to conduct high-quality clinical trials aimed at improving health outcomes across a wide range of medical fields. With a strong emphasis on ethical standards and patient welfare, IRCCS Azienda Ospedaliero-Universitaria di Bologna plays a vital role in shaping the future of medicine through rigorous scientific inquiry and patient-centered care.

Locations

Bologna, Bo, Italy

Patients applied

0 patients applied

Trial Officials

Marcello Lanari, Professor

Principal Investigator

Pediatric Emergency Unit, S. Orsola-Malpighi Hospital, University of Bologna

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials